Which assessment indicates the desired outcome of epoetin alfa therapy?

Which assessment indicates the desired outcome of epoetin alfa therapy?

• A. Hematocrit level
• B. Conjunctival sac color
• C. Platelet count
• D. Serum ferritin level

Answer: (B)

The main idea is that epoetin alfa stimulates the production of red blood cells, so the effectiveness of the therapy shows up as an increase in red cell mass. The hematocrit level directly reflects how many red cells are circulating in the blood, so rising hematocrit (along with hemoglobin) is the best indicator that epoetin alfa is working to improve anemia and oxygen-carrying capacity. Relying on the color of the conjunctival sac isn’t as reliable. It’s a crude, subjective sign of pallor that can be influenced by lighting, skin tone, or other factors, and it doesn’t quantify the actual change in red blood cell production. Platelet count doesn’t reflect erythropoiesis, and ferritin shows iron stores rather than the response to erythropoietin treatment—though having sufficient iron is important for epoetin to work, ferritin alone isn’t a direct outcome measure of the therapy’s effect. So, monitoring hematocrit (and hemoglobin) provides a precise gauge of how well epoetin alfa is achieving its goal of increasing red blood cell mass.

The main idea is that epoetin alfa stimulates the production of red blood cells, so the effectiveness of the therapy shows up as an increase in red cell mass. The hematocrit level directly reflects how many red cells are circulating in the blood, so rising hematocrit (along with hemoglobin) is the best indicator that epoetin alfa is working to improve anemia and oxygen-carrying capacity.

Relying on the color of the conjunctival sac isn’t as reliable. It’s a crude, subjective sign of pallor that can be influenced by lighting, skin tone, or other factors, and it doesn’t quantify the actual change in red blood cell production. Platelet count doesn’t reflect erythropoiesis, and ferritin shows iron stores rather than the response to erythropoietin treatment—though having sufficient iron is important for epoetin to work, ferritin alone isn’t a direct outcome measure of the therapy’s effect.

So, monitoring hematocrit (and hemoglobin) provides a precise gauge of how well epoetin alfa is achieving its goal of increasing red blood cell mass.